GlassScriptPhysician profile
Alexander A Valiga
NPI 1730640780
$1,673.77
in general payments reported to CMS, 2019-2025
17 companies · $521 in 2025
The $521 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $166 · 2021: $16.80 · 2022: $248 · 2023: $343 · 2024: $277 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,140.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $604.50 | 2022-2025 | Rinvoq |
| Kerecis Limited | $320.32 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Ucb, INC. | $144.43 | 2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $137.37 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $102.45 | 2019 | |
| Sun Pharmaceutical Industries INC. | $70.88 | 2025 | |
| Incyte Corporation | $45.49 | 2025 | Opzelura |
| Leo Pharma INC. | $44.19 | 2025 | Adbry |
| Lilly USA, LLC | $36.60 | 2024-2025 | Taltz, Ebglyss |
| E.R. Squibb & Sons, L.L.C. | $28.64 | 2020 | |
| Bard Peripheral Vascular, INC. | $26.72 | 2025 | Venclose Maven Catheter |
| Janssen Biotech, INC. | $25.28 | 2025 | Simponi Aria, Simponi, Stelara |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.09 | 2025 | Spevigo |
| Amgen INC. | $19.74 | 2025 | Otezla |
| Genzyme Corporation | $16.80 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Strata Skin Sciences, INC. | $15.25 | 2025 | Xtrac |
| Organon LLC | $12.02 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Valiga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.